scientific-programme-topics

The 15th Congress of the European Skull Base Society (ESBS) in Maastricht was distinguished not only by its vibrant setting and expert speakers but also by its comprehensive and meticulously curated scientific programme. This programme covered all critical aspects of skull base pathology, combining clinical practice, cutting-edge research, and emerging technologies. The following is an overview of the core topics that shaped the congress and drove forward the multidisciplinary discussion among specialists. Anterior and Central Skull Base

A significant portion of the congress focused on the anterior and central skull base regions, which constitute some of the most challenging anatomical and surgical areas in the field. Sessions explored advanced surgical techniques, endoscopic approaches, and innovative treatment strategies aimed at improving patient outcomes while minimizing risks. Case studies and interactive discussions allowed participants to delve into complex pathologies affecting these delicate regions, such as pituitary tumors, meningiomas, and cerebrospinal fluid leaks. Lateral Skull Base

The lateral skull base, with its intricate neurovascular structures and complex anatomy, was another focal point of the scientific programme. Presentations addressed state-of-the-art methods for pathology management in this region, including advancements in microsurgery and hearing preservation techniques. Discussions on vestibular schwannomas, facial nerve disorders, and temporal bone malignancies highlighted recent progress and ongoing challenges. Attendees benefited from multidisciplinary perspectives bridging neurosurgery, otolaryngology, and radiology. Oncology

Oncology sessions tackled the critical issue of skull base tumors, encompassing both benign and malignant neoplasms. Emphasis was placed on the identification, classification, and treatment planning for conditions such as sinonasal cancers, chordomas, and adenoid cystic carcinomas. Cutting-edge research on molecular markers, tumor biology, and targeted therapies was showcased, illustrating how personalized medicine is starting to influence skull base oncology. The role of multimodal treatment, including surgery, radiotherapy, and chemotherapy, was examined in depth. Imaging & Interventional Radiotherapy

Accurate imaging and innovative radiotherapy techniques are cornerstones in skull base diagnostics and treatment. This segment of the programme highlighted breakthroughs in high-resolution MRI, functional imaging, and novel interventional radiotherapy approaches such as stereotactic radiosurgery. The integration of imaging advances with surgical planning was a recurring theme, demonstrating how these technologies enhance precision and safety. Speakers also explored the potential of radiomics and artificial intelligence in improving diagnostic accuracy and treatment customization. Radiotherapy

Dedicated sessions on radiotherapy addressed current protocols and emerging methodologies for treating skull base tumors. Topics included fractionated radiotherapy, proton therapy, and carbon ion therapy, with a focus on balancing efficacy and side effects. Experts discussed treatment planning nuances, advancements in dose delivery, and long-term follow-up results. The programme fostered dialogue on how radiotherapy complements surgical interventions and fits into comprehensive patient care. Basic Science

Grounding the clinical advances was a robust category on basic science research related to skull base pathology. This track provided insights into fundamental mechanisms underlying tumor development, nerve regeneration, and tissue repair. Presentations covered molecular biology, genetics, and experimental models that aim to translate laboratory discoveries into clinical innovations. This emphasis highlights the ESBS congress’ commitment to fostering a continuous pipeline from bench to bedside.

The scientific programme at the 15th ESBS Congress in Maastricht succeeded in bringing together an expansive array of topics vital to the skull base community. It encouraged collaboration among surgeons, oncologists, radiologists, and researchers to share expertise and push forward the standards of diagnosis, treatment, and patient care.

Participants left with a deeper understanding of the complexities of skull base pathology and a renewed commitment to advancing the field through evidence-based, multidisciplinary approaches. The congress set a high bar for future meetings and underscored Maastricht’s role as a prime venue for scientific exchange and innovation in skull base surgery.